148 related articles for article (PubMed ID: 4425101)
1. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
[No Abstract] [Full Text] [Related]
2. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
3. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
4. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Kendall-Taylor P
Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
[TBL] [Abstract][Full Text] [Related]
5. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
Ochi Y; DeGroot LJ
Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
[No Abstract] [Full Text] [Related]
6. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
7. "Suppressible" and "non-suppressible" thyroidal radioiodine uptake of hyperthyroid glands.
Rohner R; König MP; Bucher HJ; Studer H
Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:119. PubMed ID: 4108536
[No Abstract] [Full Text] [Related]
8. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
9. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
Ason EK; Hetzel BS; Good BF; Stenhouse NS
J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
[No Abstract] [Full Text] [Related]
10. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
Beall GN; Solomon DH
J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
[No Abstract] [Full Text] [Related]
11. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
12. Direct evidence for human thyroidal stimulation by LATS-protector.
Shishiba Y; Shimizu T; Yoshimura S; Shizume K
J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
[No Abstract] [Full Text] [Related]
13. Evidence to suggest that LATS protector stimulates the human thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
[No Abstract] [Full Text] [Related]
14. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
Lepp A; Oliner L
Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
[No Abstract] [Full Text] [Related]
15. A modified bioassay for the long-acting thyroid stimulator (LATS).
Furth ED; Rathbun M; Posillico J
Endocrinology; 1969 Sep; 85(3):592-3. PubMed ID: 5793040
[No Abstract] [Full Text] [Related]
16. Sensitivity and specificity of blood and thyroid radio-iodine assays for TSH and LATS and inhibitory effect of corticosteroid.
Sharard A
N Z Med J; 1975 Jan; 81(531):21-2. PubMed ID: 1055309
[No Abstract] [Full Text] [Related]
17. Mechanism of action of di-iodotyrosine and of iodine.
Fôldes J; Gesztesi E; Juhász J
Acta Med Acad Sci Hung; 1974; 31(1-2):131-7. PubMed ID: 4464746
[No Abstract] [Full Text] [Related]
18. A modified bioassay for thyroid-stimulating hormone and long-acting thyroid stimulator.
Nutt J; Humphreys K; Clark F
J Endocrinol; 1974 Oct; 63(1):5-12. PubMed ID: 4418898
[No Abstract] [Full Text] [Related]
19. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
20. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
